All Stories

  1. Carboxylic Acids as Activators of NRF2: Antioxidant and Anti-inflammatory Effects

    Article • Medicinal Chemistry, December 2025, Bentham Science Publishers

    Dr. Melford Chuka Egbujor

  2. Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease

    Article • CNS & Neurological Disorders - Drug Targets, July 2025, Bentham Science Publishers

    Dr. Melford Chuka Egbujor

  3. Bioactive Sulfonamides Derived from Amino Acids: Their Synthesis and Pharmacological Activities

    Article • Mini-Reviews in Medicinal Chemistry, June 2025, Bentham Science Publishers

    Dr. Melford Chuka Egbujor

  4. Design, Synthesis, Molecular docking and Biological Evaluation of Novel Leucine Derived Sulfamoyl Pentanamides as Antimicrobial and Antioxidant Agents

    Article • Jordan Journal of Pharmaceutical Sciences, December 2024, The University of Jordan

    Dr. Melford Chuka Egbujor

  5. Sulfonamide derivatives are compounds for the treatment of Alzheimer's disease

    Article • Central Nervous System Agents in Medicinal Chemistry, April 2024, Bentham Science Publishers

    Dr. Melford Chuka Egbujor

  6. An insight into role of amino acids as antioxidants via NRF2 activation

    Article • Amino Acids, March 2024, Springer Science + Business Media

    Professor Luciano Saso, Dr. Melford Chuka Egbujor

  7. Phenothiazines are non‐electrophilic Nrf2 activator and free radical scavengers scavengers.

    Article • Journal of Biochemical and Molecular Toxicology, February 2024, Wiley

    Dr. Melford Chuka Egbujor

  8. NRF2 Activation by Nitrogen Heterocycles: A Review

    Article • Molecules, March 2023, MDPI AG

    Professor Luciano Saso, Dr. Melford Chuka Egbujor

  9. Sulfonamide a Valid Scaffold for Antioxidant Drug Development

    Article • Mini-Reviews in Organic Chemistry, March 2023, Bentham Science Publishers

    Professor Fernanda Borges, Professor Luciano Saso, Dr. Melford Chuka Egbujor